ConductScience.org, home

Paper36980965

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.

Neuckermans J and 13 others. Genes (Basel), 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Papers, record 36980965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980965

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.
PubMed
Journal
Genes (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.65
iCite
Revised in PubMed
2026-09-19
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Neuckermans JJessiehttps://orcid.org/0000-0002-7158-7860
2Lequeue SSienhttps://orcid.org/0000-0001-8345-3969
3Claes PPaul
4Heymans AAnja
5Hughes JHJuliette Hhttps://orcid.org/0000-0001-6155-4136
6Colemonts-Vroninks HHaaikehttps://orcid.org/0000-0003-0123-9630
7Marcélis LLionelhttps://orcid.org/0000-0002-6324-477X
8Casimir GGeorgeshttps://orcid.org/0000-0001-7332-8793
9Goyens PPhilippe
10Martens GAGeert A
11Gallagher JAJames A
12Vanhaecke TTamara
13Bou-Gharios GGeorgehttps://orcid.org/0000-0002-9563-9418
14De Kock JJoeryhttps://orcid.org/0000-0002-4078-4896

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
TyrosinemiasMajor topic
Liver NeoplasmsMajor topic
Mice
Animals
Phenotype
Tyrosine
Cyclohexanones
Nitrobenzoates

Source PubMed

Download CSV of topics

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121042596Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.PLoS One2010https://conductscience.org/library/papers/21042596PubMed
228771246Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.Genet Med2017https://conductscience.org/library/papers/28771246PubMed
333046095Type 1 tyrosinemia in Finland: a nationwide study.Orphanet J Rare Dis2020https://conductscience.org/library/papers/33046095PubMed
434676172β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation.Front Oncol2021https://conductscience.org/library/papers/34676172PubMed
536376482A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria.Sci Rep2022https://conductscience.org/library/papers/36376482PubMed
625266991The role of nitisinone in tyrosine pathway disorders.Curr Rheumatol Rep2014https://conductscience.org/library/papers/25266991PubMed
728949985Presumptive brain influx of large neutral amino acids and the effect of phenylalanine supplementation in patients with Tyrosinemia type 1.PLoS One2017https://conductscience.org/library/papers/28949985PubMed
826360553Molecular changes associated with chronic liver damage and neoplastic lesions in a murine model of hereditary tyrosinemia type 1.Biochim Biophys Acta2015https://conductscience.org/library/papers/26360553PubMed
921112803Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I.Mol Genet Metab2011https://conductscience.org/library/papers/21112803PubMed
1035129276Common variant p.D19H of the hepatobiliary sterol transporter ABCG8 increases the risk of gallstones in children.Liver Int2022https://conductscience.org/library/papers/35129276PubMed
1122554029Hereditary tyrosinaemia type I in Norway: incidence and three novel small deletions in the fumarylacetoacetase gene.Scand J Clin Lab Invest2012https://conductscience.org/library/papers/22554029PubMed
1231578365A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.Sci Rep2019https://conductscience.org/library/papers/31578365PubMed
1325804398Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.Eur J Hum Genet2016https://conductscience.org/library/papers/25804398PubMed
1425665838Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.JIMD Rep2015https://conductscience.org/library/papers/25665838PubMed
1523764751Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.Br J Cancer2013https://conductscience.org/library/papers/23764751PubMed
1611232358Nontransplant treatment of tyrosinemia.Clin Liver Dis2000https://conductscience.org/library/papers/11232358PubMed
1722885033Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Québec.Mol Genet Metab2012https://conductscience.org/library/papers/22885033PubMed
1827356512Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls.Orphanet J Rare Dis2016https://conductscience.org/library/papers/27356512PubMed
1936253445The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.Oncogene2022https://conductscience.org/library/papers/36253445PubMed
2023311542Recommendations for the management of tyrosinaemia type 1.Orphanet J Rare Dis2013https://conductscience.org/library/papers/23311542PubMed

See all 52 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41590629Untargeted Metabolomics Reveals Metabolic Reprogramming Linked to HCC Risk in Late Diagnosed Tyrosinemia Type 1.Metabolites2025https://conductscience.org/library/papers/41590629PubMed
41454338Discovery of newborn Wilson disease biomarkers via integrated next-generation sequencing and untargeted metabolomics.Orphanet J Rare Dis2025https://conductscience.org/library/papers/41454338PubMed
40989158The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer.Open Med (Wars)2025https://conductscience.org/library/papers/40989158PubMed
37906252Signaling metabolite succinylacetone activates HIF-1α and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma.JCI Insight2023https://conductscience.org/library/papers/37906252PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980965

GET https://conductscience.org/api/papers/v1/36980965/references?page=2